Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets open in 3 hours 6 minutes
NIKKEI 225
38,313.35
-92.31
(-0.24%)
HANG SENG
17,763.03
+16.12
(+0.09%)
CRUDE OIL
81.13
-0.80
(-0.98%)
GOLD FUTURES
2,295.90
-7.00
(-0.30%)
DOW
37,815.92
-570.17
(-1.49%)
Bitcoin GBP
48,243.56
-2,818.64
(-5.52%)
Stocks
Trending tickers: Amazon, Tesla, Samsung, Mercedes-Benz, Whitbread
The latest investor updates on stocks that are trending on Tuesday
JCR Pharmaceuticals Co., Ltd. (4552.T)
Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
805.00
-10.00
(-1.23%)
As of 12:34PM JST. Market open.
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
41,365,000
34,343,000
51,082,000
30,085,000
Cost of revenue
10,410,000
8,886,000
10,461,000
7,812,000
Gross profit
30,955,000
25,456,000
40,620,000
22,272,000
Operating expenses
Total operating expenses
23,123,000
20,480,000
20,686,000
14,003,000
Operating income or loss
7,832,000
4,976,000
19,934,000
8,269,000
Interest expense
74,000
44,000
45,000
42,000
Income before tax
7,503,000
5,412,000
19,404,000
8,653,000
Income tax expense
2,129,000
1,625,000
4,886,000
1,764,000
Income from continuing operations
5,374,000
3,787,000
14,518,000
6,889,000
Net income
5,364,000
3,772,000
14,507,000
6,892,000
Net income available to common shareholders
5,364,000
3,772,000
14,507,000
6,892,000
Basic EPS
64.68
30.35
117.26
55.81
Diluted EPS
64.38
30.22
116.80
55.53
Basic average shares
124,735
124,308
123,720
123,517
Diluted average shares
125,358
124,818
124,204
124,113
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.